A Practical Method for Targeted Library Design Balancing Lead‐like Properties with Diversity

No abstract is available for this paper.

• Publication year

  2009

• Venue

  ChemMedChem

• Publication date

  2009-05-11

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1002/cmdc.200900050PMID 19360802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships.

  2008cited by this paper
• 2,6-Diazaspiro[3.3]heptanes: synthesis and application in Pd-catalyzed aryl amination reactions.

  2008cited by this paper
• 4.18 – Lead Discovery and the Concepts of Complexity and Lead-Likeness in the Evolution of Drug Candidates

  2007cited by this paper
• Origin and evolution of high throughput screening

  2007cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Topography-biased compound library design: the shape of things to come?

  2007cited by this paper
• Synthesis of novel 2,6-diazaspiro[3.3]heptanes

  2007cited by this paper
• A high-throughput screen for aggregation-based inhibition in a large compound library.

  2007cited by this paper
• 2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.

  2006cited by this paper
• An Empirical Process for the Design of High-Throughput Screening Deck Filters

  2006cited by this paper
• Compound Management and Enhancement Activities in AstraZeneca

  2005cited by this paper
• High-throughput assays for promiscuous inhibitors

  2005cited by this paper
• High-throughput drug discovery: what can we expect from HTS?

  2005cited by this paper
• Components of successful lead generation.

  2005cited by this paper
• Design of a compound screening collection for use in high throughput screening.

  2004cited by this paper
• Characteristic physical properties and structural fragments of marketed oral drugs.

  2004cited by this paper
• Selective optimization of side activities: another way for drug discovery.

  2004cited by this paper
• Pursuing the leadlikeness concept in pharmaceutical research.

  2004cited by this paper
• Research Papers) Design of a Compound Screening Collection for use in High Throughput Screening

  2004cited by this paper
• Drug-like properties: guiding principles for design - or chemical prejudice?

  2004cited by this paper
• A comparison of physiochemical property profiles of development and marketed oral drugs.

  2003cited by this paper
• Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity

  2003cited by this paper
• Size doesn't matter: Scaffold diversity shape diversity, and biological activity of combinatorial libraries

  2003cited by this paper
• A novel approach to combinatorial library design.

  2002cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• Do structurally similar molecules have similar biological activity?

  2002cited by this paper
• Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes.

  2001cited by this paper
• Is There a Difference between Leads and Drugs? A Historical Perspective

  2001cited by this paper
• Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 1: design of potent and specific 3,9-diazaspiro[5.5]undecanes.

  2001cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• HTS in the new millennium: the role of pharmacology and flexibility.

  2000cited by this paper
• The Design of Leadlike Combinatorial Libraries.

  1999cited by this paper
• Design kombinatorischer Leitstruktur‐Bibliotheken

  1999cited by this paper
• Chapter 30 – Current and Future Trends in High Throughput Screening for Drug Discovery

  1998cited by this paper
• Reactive compounds and in vitro false positives in HTS

  1997cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• A New Reduction of Some Carboxylic Esters with Sodium Borohydride and Zinc Chloride in the Presence of a Tertiary Amine

  1991cited by this paper
• A novel rearrangement reaction conversion of 3-(chloromethyl)azetidin-2-ones to azetidine-3-carboxylic acid esters

  1991cited by this paper
• Quinolone antibacterial agents substituted at the 7-position with spiroamines. Synthesis and structure-activity relationships.

  1990cited by this paper
• Activated Dimethyl Sulfoxide: Useful Reagents for Synthesis

  1981cited by this paper

• Non-Extensive Fragmentation of Natural Products and Pharmacophore-Based Virtual Screening as a Practical Approach to Identify Novel Promising Chemical Scaffolds

  2021cites this paper
• Saturated Heterocyclic Aminosulfonyl Fluorides: New Scaffolds for Protecting-Group-Free Synthesis of Sulfonamides.

  2018cites this paper
• Analysing and Navigating Natural Products Space for Generating Small, Diverse, But Representative Chemical Libraries

  2018cites this paper
• New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm.

  2018cites this paper
• Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase-4 (DPP-4), Antagonists of the C-C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol-3 Kinase δ (PI3Kδ) Inhibitors.

  2017cites this paper
• Privileged Structures and Motifs (Synthetic and Natural Scaffolds)

  2017cites this paper
• Design and Synthesis of Fsp(3)-Rich, Bis-Spirocyclic-Based Compound Libraries for Biological Screening.

  2016cites this paper
• Lead Generation Based on Compound Collection Screening

  2016cites this paper
• Development and validation of in silico tools for efficient library design and data analysis in high throughput screening campaigns

  2015cites this paper
• Studies on the formal [3 + 2] cycloaddition of aziridines with alkenes for the synthesis of 1-azaspiroalkanes.

  2015cites this paper
• 11. Advances in the Understanding of Drug Properties in Medicinal Chemistry

  2015cites this paper
• Designing novel building blocks is an overlooked strategy to improve compound quality.

  2015cites this paper
• Synthesis of 1,5-diazaspiro[2.3]hexanes, a novel diazaspirocyclic system

  2013cites this paper
• Established and emerging trends in computational drug discovery in the structural genomics era.

  2012cites this paper
• Scalable synthesis of 1-bicyclo[1.1.1]pentylamine via a hydrohydrazination reaction.

  2011cites this paper
• Chemoinformatics and library design.

  2011cites this paper
• Synthesis and structural analysis of a new class of azaspiro[3.3]heptanes as building blocks for medicinal chemistry.

  2010cites this paper
• Synthesis of azaspirocycles and their evaluation in drug discovery.

  2010cites this paper
• Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

  2010cites this paper
• Identification of potent ITK inhibitors through focused compound library design including structural information.

  2010cites this paper
• Data-mining patent literature for novel chemical reagents for use in medicinal chemistry design

  2010cites this paper
• Synthese von azaspirocyclischen Bausteinen und deren Evaluierung für die Wirkstoff‐Forschung

  2010cites this paper
• High Throughput Screening Approach to Lead Discovery

  2010cites this paper